Format

Send to

Choose Destination
Indian J Clin Biochem. 2006 Mar;21(1):54-61. doi: 10.1007/BF02913067.

Sialic acid in cardiovascular diseases.

Author information

1
Department of Cardiology, King George's Medical University, 226 003 Lucknow.

Abstract

Sialic acid, the acylated derivatives of 9-carbon sugar neuraminic acid, present as terminal component of oligosaccharide chains of many glycoproteins and glycolipids, has been recognized to be involved in the regulation of a great variety of biological phenomena. Studies have shown that serum sialic acid predicts both coronary heart disease and stroke mortality and reflects the existence or activity of an atherosclerotic process. Most of the studies have shown an elevation in serum sialic acid concentration in coronary heart disease and a positive correlation between the raised serum sialic acid and the severity of the coronary lesions is observed. However, a few contradictory reports are also available. Racial differences in serum sialic acid have also been reported and correlated with international differences in the prevalence of atherosclerosis. Reduced sialic acid content of platelets, erythrocytes and lipoproteins may play important role in the pathogenesis of atherosclerosis. Elucidation of the mechanism of alternation in sialic acid concentration may throw more light on its potential clinical utility. Hence more studies are needed to designates sialic acid as a cardiovascular risk factor/marker.

KEYWORDS:

Cardiovascular diseases; Sialic Acid

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center